Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.

Remon J, Isla D, Garrido P, de Castro J, Majem M, Viñolas N, Artal A, Carcereny E, García-Campelo MR, Lianes P, Provencio M, Juan O, Diz P, Blanco R, Lopez-Castro R, Maestu I, Vadell C, Felip E.

Clin Transl Oncol. 2017 Dec;19(12):1537-1542. doi: 10.1007/s12094-017-1700-8. Epub 2017 Jun 28.

PMID:
28660482
2.

Lung Cancer in Never-Smoking Women: A Sub-Analysis of the Spanish Female-Specific Database WORLD07.

Viñolas N, Garrido P, Isla D, Provencio M, Majem M, Artal A, Carcereny E, Garcia Campelo R, Lianes P, De La Peñas R, Felip E.

Cancer Invest. 2017 May 28;35(5):358-365. doi: 10.1080/07357907.2017.1295461. Epub 2017 Mar 28.

PMID:
28350480
3.

Erratum to: Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.

Salvador J, Aparicio J, Baron FJ, García-Campelo R, Garcia-Carbonero R, Lianes P, Llombart A, Isla D, Piera JM, Muñoz M, Puente J, Rivera F, Rodríguez CA, Virizuela JA, Martín M, Garrido P.

Clin Transl Oncol. 2017 Apr;19(4):525. doi: 10.1007/s12094-017-1628-z. No abstract available.

PMID:
28243989
4.

Medical oncology future plan of the Spanish Society of Medical Oncology: challenges and future needs of the Spanish oncologists.

Rivera F, Andres R, Felip E, Garcia-Campelo R, Lianes P, Llombart A, Piera JM, Puente J, Rodriguez CA, Vera R, Virizuela JA, Martin M, Garrido P.

Clin Transl Oncol. 2017 Apr;19(4):508-518. doi: 10.1007/s12094-016-1595-9. Epub 2016 Dec 22. Review.

5.

Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07.

Isla D, Felip E, Viñolas N, Provencio M, Majem M, Artal A, Bover I, Lianes P, DE Las Peñas R, Catot S, DE Castro J, Blasco A, Terrasa J, Gonzalez-Larriba JL, Juan O, Dómine M, Bernabe R, Garrido P.

Anticancer Res. 2016 Dec;36(12):6647-6653.

PMID:
27919997
6.

A consensus statement on the gender perspective in lung cancer.

Isla D, Majem M, Viñolas N, Artal A, Blasco A, Felip E, Garrido P, Remón J, Baquedano M, Borrás JM, Die Trill M, García-Campelo R, Juan O, León C, Lianes P, López-Ríos F, Molins L, Planchuelo MÁ, Cobo M, Paz-Ares L, Trigo JM, de Castro J.

Clin Transl Oncol. 2017 May;19(5):527-535. doi: 10.1007/s12094-016-1578-x. Epub 2016 Nov 24. Review.

PMID:
27885542
7.

Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions.

Salvador J, Aparicio J, Baron FJ, Garcia-Campelo R, Garcia-Carbonero R, Lianes P, Llombart A, Isla D, Piera JM, Munoz M, Puente J, Rivera F, Rodriguez CA, Virizuela JA, Martin M, Garrido P.

Clin Transl Oncol. 2017 Mar;19(3):341-356. doi: 10.1007/s12094-016-1535-8. Epub 2016 Aug 25. Erratum in: Clin Transl Oncol. 2017 Apr;19(4):525. multiple author names corrected.

8.

miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.

Remon J, Alvarez-Berdugo D, Majem M, Moran T, Reguart N, Lianes P.

Clin Transl Oncol. 2016 Feb;18(2):153-9. doi: 10.1007/s12094-015-1347-2. Epub 2015 Jul 22.

PMID:
26199015
9.

Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies.

Remon J, Reguart N, Corral J, Lianes P.

Cancer Treat Rev. 2015 Jan;41(1):27-34. doi: 10.1016/j.ctrv.2014.10.007. Epub 2014 Nov 8. Review.

PMID:
25467107
10.

Thyroid cancer: SEOM clinical guidelines.

Trigo JM, Capdevila J, Grande E, Grau J, Lianes P; Spanish Society for Medical Oncology.

Clin Transl Oncol. 2014 Dec;16(12):1035-42. doi: 10.1007/s12094-014-1224-4. Epub 2014 Sep 23.

11.

Beyond EGFR TKI in EGFR-mutant non-small cell lung cancer patients: main challenges still to be overcome.

Remon J, Morán T, Reguart N, Majem M, Carcereny E, Lianes P.

Cancer Treat Rev. 2014 Jul;40(6):723-9. doi: 10.1016/j.ctrv.2014.03.006. Epub 2014 Apr 12. Review.

PMID:
24759598
12.

Lung cancer in women: an overview with special focus on Spanish women.

Remon J, Molina-Montes E, Majem M, Lianes P, Isla D, Garrido P, Felip E, Viñolas N, de Castro J, Artal A, Sánchez MJ.

Clin Transl Oncol. 2014 Jun;16(6):517-28. doi: 10.1007/s12094-013-1137-7. Epub 2013 Nov 26. Review.

PMID:
24277573
13.

Acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer: a new era begins.

Remon J, Morán T, Majem M, Reguart N, Dalmau E, Márquez-Medina D, Lianes P.

Cancer Treat Rev. 2014 Feb;40(1):93-101. doi: 10.1016/j.ctrv.2013.06.002. Epub 2013 Jul 3. Review.

PMID:
23829935
14.

Adjuvant treatment in resected non-small cell lung cancer: current and future issues.

Remon J, Lianes P, Martínez S, Velasco M, Querol R, Zanui M.

Crit Rev Oncol Hematol. 2013 Nov;88(2):375-86. doi: 10.1016/j.critrevonc.2013.05.017. Epub 2013 Jul 1. Review.

PMID:
23809199
15.

Malignant mesothelioma: new insights into a rare disease.

Remon J, Lianes P, Martínez S, Velasco M, Querol R, Zanui M.

Cancer Treat Rev. 2013 Oct;39(6):584-91. doi: 10.1016/j.ctrv.2012.12.005. Epub 2012 Dec 28. Review.

PMID:
23276688
16.

SEOM guidelines for the treatment of malignant pleural mesothelioma.

Lianes P, Remon J, Bover I, Isla D.

Clin Transl Oncol. 2011 Aug;13(8):569-73. doi: 10.1007/s12094-011-0699-5.

PMID:
21821492
17.

Brain metastases from renal cell carcinoma. Should we change the current standard?

Remon J, Lianes P, Martínez S.

Cancer Treat Rev. 2012 Jun;38(4):249-57. doi: 10.1016/j.ctrv.2011.06.008. Epub 2011 Jul 20. Review.

PMID:
21767916
18.

First-line therapy and methylation status of CHFR in serum influence outcome to chemotherapy versus EGFR tyrosine kinase inhibitors as second-line therapy in stage IV non-small-cell lung cancer patients.

Salazar F, Molina MA, Sanchez-Ronco M, Moran T, Ramirez JL, Sanchez JM, Stahel R, Garrido P, Cobo M, Isla D, Bertran-Alamillo J, Massuti B, Cardenal F, Manegold C, Lianes P, Trigo JM, Sanchez JJ, Taron M, Rosell R.

Lung Cancer. 2011 Apr;72(1):84-91. doi: 10.1016/j.lungcan.2010.07.008. Epub 2010 Aug 11.

PMID:
20705357
19.

Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation.

Porta R, Sánchez-Torres JM, Paz-Ares L, Massutí B, Reguart N, Mayo C, Lianes P, Queralt C, Guillem V, Salinas P, Catot S, Isla D, Pradas A, Gúrpide A, de Castro J, Polo E, Puig T, Tarón M, Colomer R, Rosell R.

Eur Respir J. 2011 Mar;37(3):624-31. doi: 10.1183/09031936.00195609. Epub 2010 Jul 1.

20.

Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer.

Rosell R, Manegold C, Moran T, Garrido P, Blanco R, Lianes P, Stahel R, Trigo JM, Wei J, Taron M.

Clin Lung Cancer. 2008 Mar;9 Suppl 2:S76-82. doi: 10.3816/CLC.2008.s.012. Review.

PMID:
21885003
21.

Weekly administration of docetaxel in combination with estramustine and celecoxib in patients with advanced hormone-refractory prostate cancer: final results from a phase II study.

Carles J, Font A, Mellado B, Domenech M, Gallardo E, González-Larriba JL, Catalan G, Alfaro J, Gonzalez Del Alba A, Nogué M, Lianes P, Tello JM.

Br J Cancer. 2007 Nov 5;97(9):1206-10. Epub 2007 Oct 23.

22.

Blindness in a bladder cancer patient.

Remón J, Guardeño R, Badía A, Cardona T, Picaza JM, Lianes P.

Clin Transl Oncol. 2007 Feb;9(2):117-8.

PMID:
17329224
23.

Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975.

Efficace F, Bottomley A, Smit EF, Lianes P, Legrand C, Debruyne C, Schramel F, Smit HJ, Gaafar R, Biesma B, Manegold C, Coens C, Giaccone G, Van Meerbeeck J; EORTC Lung Cancer Group and Quality of Life Unit.

Ann Oncol. 2006 Nov;17(11):1698-704. Epub 2006 Sep 12.

PMID:
16968876
24.

Economic evaluation of three two-drug chemotherapy regimens in advanced non-small-cell lung cancer.

Neymark N, Lianes P, Smit EF, van Meerbeeck JP.

Pharmacoeconomics. 2005;23(11):1155-66.

PMID:
16277550
25.

Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma.

Manegold C, Symanowski J, Gatzemeier U, Reck M, von Pawel J, Kortsik C, Nackaerts K, Lianes P, Vogelzang NJ.

Ann Oncol. 2005 Jun;16(6):923-7. Epub 2005 Apr 11.

PMID:
15824080
26.

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.

Isla D, Sarries C, Rosell R, Alonso G, Domine M, Taron M, Lopez-Vivanco G, Camps C, Botia M, Nuñez L, Sanchez-Ronco M, Sanchez JJ, Lopez-Brea M, Barneto I, Paredes A, Medina B, Artal A, Lianes P.

Ann Oncol. 2004 Aug;15(8):1194-203.

PMID:
15277258
27.

Incidence of contralateral germ cell testicular tumors in South Europe: report of the experience at 2 Spanish university hospitals and review of the literature.

Tabernero J, Paz-Ares L, Salazar R, Lianes P, Guerra J, Borrás J, Villavicencio H, Leiva O, Cortés-Funes H.

J Urol. 2004 Jan;171(1):164-7. Review.

PMID:
14665868
28.

Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group--EORTC 08975.

Smit EF, van Meerbeeck JP, Lianes P, Debruyne C, Legrand C, Schramel F, Smit H, Gaafar R, Biesma B, Manegold C, Neymark N, Giaccone G; European Organization for Research and Treatment of Cancer Lung Cancer Group.

J Clin Oncol. 2003 Nov 1;21(21):3909-17.

PMID:
14581415
29.

European organization for research and treatment of cancer (EORTC) 08957 phase II study of topotecan in combination with cisplatin as second-line treatment of refractory and sensitive small cell lung cancer.

Ardizzoni A, Manegold C, Debruyne C, Gaafar R, Buchholz E, Smit EF, Lianes P, ten Velde G, Bosquee L, Legrand C, Neumaier C, King K; Giuseppe giaccone European organization for research and treatment of cancer (EORTC) lung cancer group.

Clin Cancer Res. 2003 Jan;9(1):143-50.

30.

Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial.

Rosell R, Gatzemeier U, Betticher DC, Keppler U, Macha HN, Pirker R, Berthet P, Breau JL, Lianes P, Nicholson M, Ardizzoni A, Chemaissani A, Bogaerts J, Gallant G.

Ann Oncol. 2002 Oct;13(10):1539-49.

PMID:
12377641
31.
32.

[Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients].

Germà JR, García Del Muro X, Maroto P, Lianes P, Arranz JA, Gumà J, Aparicio J, Sastre J, Alba E, Terrasa J, Sáenz A, Fernández A; Grupo Germinal.

Med Clin (Barc). 2001 Apr 7;116(13):481-6. Spanish.

PMID:
11412604
33.

Tumor markers at the time of recurrence in patients with germ cell tumors.

Trigo JM, Tabernero JM, Paz-Ares L, García-Llano JL, Mora J, Lianes P, Esteban E, Salazar R, López-López JJ, Cortés-Funes H.

Cancer. 2000 Jan 1;88(1):162-8.

PMID:
10618619
34.

Randomized phase III study of gemcitabine-cisplatin versus etoposide-cisplatin in the treatment of locally advanced or metastatic non-small-cell lung cancer.

Cardenal F, López-Cabrerizo MP, Antón A, Alberola V, Massuti B, Carrato A, Barneto I, Lomas M, García M, Lianes P, Montalar J, Vadell C, González-Larriba JL, Nguyen B, Artal A, Rosell R.

J Clin Oncol. 1999 Jan;17(1):12-8.

PMID:
10458212
35.

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type.

Hasbini A, Mahjoubi R, Fandi A, Chouaki N, Taamma A, Lianes P, Cortès-Funes H, Alonso S, Armand JP, Cvitkovic E, Raymond E.

Ann Oncol. 1999 Apr;10(4):421-5.

PMID:
10370784
36.

Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relatives.

Garcia-Patińo E, Gomendio B, Silva JM, Garcia JM, Provencio M, Perez-Carrion R, Lianes P, Casado A, Espańa P, Bonilla F.

Int J Oncol. 1998 Aug;13(2):275-9.

PMID:
9664122
37.

A phase II study of a novel gemcitabine plus cisplatin regimen administered every three weeks for advanced non-small-cell lung cancer.

Castellano D, Lianes P, Paz-Ares L, Hidalgo M, Guerra JA, Gómez-Martín C, Gómez H, Calzas J, Cortés-Funes H.

Ann Oncol. 1998 Apr;9(4):457-9.

PMID:
9636840
38.

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

Giaccone G, Splinter TA, Debruyne C, Kho GS, Lianes P, van Zandwijk N, Pennucci MC, Scagliotti G, van Meerbeeck J, van Hoesel Q, Curran D, Sahmoud T, Postmus PE.

J Clin Oncol. 1998 Jun;16(6):2133-41.

PMID:
9626213
39.

[Heart pathology of extracardiac origin. VII. Heart and neoplasms].

Calzas J, Lianes P, Cortés-Funes H.

Rev Esp Cardiol. 1998 Apr;51(4):314-31. Review. Spanish.

40.

Biomarker study of primary nonmetastatic versus metastatic invasive bladder cancer. National Cancer Institute Bladder Tumor Marker Network.

Lianes P, Charytonowicz E, Cordon-Cardo C, Fradet Y, Grossman HB, Hemstreet GP, Waldman FM, Chew K, Wheeless LL, Faraggi D.

Clin Cancer Res. 1998 May;4(5):1267-71.

41.

[Long-term course of blood lipids and body mass index in patients with testicular cancer treated with chemotherapy].

Fernández-Miranda C, Schoebel N, Angulo A, Paz-Ares L, Lianes P, del Palacio A.

Rev Clin Esp. 1997 Jul;197(7):490-3. Spanish.

PMID:
9411545
42.

Mediastinal non-seminomatous germ cell tumours (MNSGCT) treated with cisplatin-based combination chemotherapy.

Hidalgo M, Paz-Ares L, Rivera F, Lianes P, Huidobro G, Ruiz A, López-Brea M, Sanz-Ortiz J, López López J, Cortés-Funes H, Tabernero JM.

Ann Oncol. 1997 Jun;8(6):555-9.

PMID:
9261524
43.

Cigarette smoking and chromosome 9 alterations in bladder cancer.

Zhang ZF, Shu XM, Cordon-Cardo C, Orlow I, Lu ML, Millon TV, Cao PQ, Connolly-Jenks C, Dalbagni G, Lianes P, Lacombe L, Reuter VE, Scher H.

Cancer Epidemiol Biomarkers Prev. 1997 May;6(5):321-6.

44.

Final report of a phase II study of chemotherapy with bleomycin, epirubicin, and cisplatin for locally advanced and metastatic/recurrent undifferentiated carcinoma of the nasopharyngeal type.

Azli N, Fandi A, Bachouchi M, Rahal M, Lianes P, Wibault P, Boussen H, Eschwege F, Armand JP, Cvitkovic E.

Cancer J Sci Am. 1995 Sep-Oct;1(3):222-9.

PMID:
9166480
45.

Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma.

Motzer RJ, Lyn P, Fischer P, Lianes P, Ngo RL, Cordon-Cardo C, O'Brien JP.

J Clin Oncol. 1995 Aug;13(8):1958-65.

PMID:
7636536
46.

Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.

Mayordomo JI, Rivera F, Díaz-Puente MT, Lianes P, Colomer R, López-Brea M, López E, Paz-Ares L, Hitt R, García-Ribas I, et al.

J Natl Cancer Inst. 1995 Jun 7;87(11):803-8.

PMID:
7540696
47.

Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.

Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J, Cordon-Cardo C.

Clin Cancer Res. 1995 May;1(5):545-50.

48.

Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression.

Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, et al.

Am J Pathol. 1995 May;146(5):1199-206.

49.

Physical symptoms and psychological distress among patients with HIV infection.

Gil F, Arranz P, Lianes P, Breitbart W.

AIDS Patient Care. 1995 Feb;9(1):28-31. Review.

PMID:
11361352
50.

[A randomized study of navelbine compared to navelbine and cisplatin compared to vindesine and cisplatin in the treatment of inoperable non-small-cell lung carcinoma. The results of a European multicenter study including 612 patients].

González Larriba JL, Alberola V, Lianes P, Panizo A, Carrato A, Muñoz Quintana A, Cardenal F, Gracia JM, Moyano A, Díaz-Rubio E, et al.

Rev Clin Esp. 1994 Nov;194(11):953-9. Spanish.

PMID:
7846351

Supplemental Content

Loading ...
Support Center